Proton Pump Inhibitors and Fracture Risk: de nada or more Aggita?
Track
:
CLINICAL
Program Code:
S60-2
Date:
Monday, June 21, 2010
Time:
4:15 PM to 4:45 PM
EST
Location:
20D
SPEAKER
:
Karl Leonard Insogna, MD, Yale Univ Sch of Med, New Haven, CT Disclosure: Nothing to Disclose
Karl L. Insogna, M.D., received his medical degree from the University of Connecticut School of Medicine, Farmington, Ct. He is a tenured Professor in Medicine at Yale University. He is the Director of the Yale Bone Center, a multi-specialty skeletal diseases service, and the Yale Core Center for Musculoskeletal Disorders, a NIAMS-funded P30 Core Center. He is also the Associate Director of the Yale Center for X-linked Hypophosphatemia. He is a member of the American Society for Clinical Investigation and a Fellow of the American Association for the Advancement of Science. Dr. Insogna is an internationally recognized expert in metabolic bone disease, and has published widely on both basic science and clinical problems in this field including articles in the Journal of Clinical Endocrinology and Metabolism, Endocrinology, JCI, Cell, and Science. One focus of his current clinical research program is the impact of dietary protein on bone health.